Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04102566 · ClinicalTrials.gov registry record · Phase 4
Optimizing Pain Control in Transurethral Resection of the Prostate
A Phase 4 study of Pain and BPH With Urinary Obstruction, sponsored by Benaroya Research Institute.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04102566: Recruiting Phase 4 study of Pain and BPH With Urinary Obstruction, sponsored by Benaroya Research Institute.
NCT04102566 is a Phase 4 study of Pain and BPH With Urinary Obstruction that is actively recruiting participants, run by Benaroya Research Institute. The registered enrollment target is 50 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04102566, a Phase 4 study of Pain and BPH With Urinary Obstruction, is actively recruiting participants, sponsored by Benaroya Research Institute.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a multi-modal protocol for pain management after TURP that minimizes opioid use. The investigators hypothesize this approach will provide non-inferior pain control to the current standard of care which includes opioids as the primary agent. The investigators believe this is an important step in reducing the opioid epidemic in surgical patients.
Primary Outcome
Total opioid utilization
Conditions Studied
Interventions
- DRUG Ibuprofen 600 mg
- BEHAVIORAL Education
Study Locations (1)
Washington
- Virginia Mason Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-12-08 |
| Est. Completion | 2019-12-01 |
| Phase | Phase 4 |
What NCT04102566 shows while recruiting
NCT04102566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Ibuprofen 600 mg is the first listed.
NCT04102566 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04102566 about?
NCT04102566 is a clinical study titled "Optimizing Pain Control in Transurethral Resection of the Prostate". The purpose of this study is to develop a multi-modal protocol for pain management after TURP that minimizes opioid use. The investigators hypothesize this approach will provide non-inferior pain control to the current standard of care which includes opioids as the primary agent. The investigators b...
What is the current status of trial NCT04102566?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2017-12-08. Estimated completion is 2019-12-01.
What conditions does trial NCT04102566 study?
This clinical trial studies the following conditions: Pain, BPH With Urinary Obstruction, BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms.
What interventions are being tested in trial NCT04102566?
The interventions under investigation include: Ibuprofen 600 mg (DRUG), Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT04102566?
This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04102566 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04102566's enrollment target sits among peer trials
50 254th of 374 higher than 111 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
-
Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI